1 January 2023 in Digital Health
Objective: This review paper aims to evaluate existing solutions in healthcare authentication and provides an insight into the technologies incorporated in Internet of Healthcare Things (IoHT) and multi-factor authentication (MFA) applications for next-generation authentication practices. Our review has two objectives: (a) Review MFA based on the challenges, impact and solutions discussed in the literature; and (b) define the security requirements of the IoHT as an approach to adapting MFA solutions in a healthcare context. Methods: To review the existing literature, we indexed articles from the IEEE Xplore, ACM Digital Library, ScienceDirect, and SpringerLink databases. The search was refined to combinations of ‘authentication’, ‘multi-factor authentication’, ‘Internet of Things authentication’, and ‘medical authentication’ to ensure that the retrieved journal articles and conference papers were relevant to healthcare and Internet of Things-oriented authentication research. Results: The concepts of MFA can be applied to healthcare where security can often be overlooked. The security requirements identified result in stronger methodologies of authentication such as hardware solutions in combination with biometric data to enhance MFA approaches. We identify the key vulnerabilities of weaker approaches to security such as password use against various cyber threats. Cyber threats and MFA solutions are categorised in this paper to facilitate readers’ understanding of them in healthcare domains. Conclusions: We contribute to an understanding of up-to-date MFA approaches and how they can be improved for use in the IoHT. This is achieved by discussing the challenges, benefits, and limitations of current methodologies and recommendations to improve access to eHealth resources through additional layers of security.
20 June 2022 in Dermatological Reviews
Vitiligo is a chronic skin condition that results in depigmentation. It affects up to 2% of the population worldwide. Phototherapy is one of the most commonly used treatment methods for vitiligo. In the last few decades, there has been an increasing popularity of narrowband ultraviolet B phototherapy (NB‐UVB) over other forms of phototherapy to treat vitiligo. This paper reviews efficacy and safety of NB‐UVB treatment in vitiligo, including combination therapy with topical calcineurin inhibitors, corticosteroids, vitamin D analogs, antioxidants, and fractional CO2 laser. Advantages and limitations of home‐based phototherapy as an emerging alternative to conventional hospital‐based phototherapy will also be explored.
12 July 2024 in Clinical and Experimental Dermatology
Acquired dermal macular hyperpigmentation (ADMH) encompasses conditions including lichen planus pigmentosus, erythema dyschromicum perstans, ashy dermatosis, Riehl melanosis and pigmented contact dermatitis. This group of cosmetically distressing pigmentary disorders poses a therapeutic challenge, yet to our knowledge, there have been no systematic reviews published that describe their impact on quality of life (QoL). An electronic database search of PubMed, Embase, PsycINFO and Cochrane Library was performed in December 2022 to search for articles published from inception until 15 December 2022. Articles were included if they (i) were a primary clinical publication, (ii) reported QoL in patients with ADMH, and (iii) were available in full text. Overall, the review highlighted a considerable gap in the literature concerning the impact of ADMH on QoL. Seven studies fulfilling the inclusion criteria were included, with a total of 259 patients. All seven studies reported impaired QoL in patients with ADMH. The currently available literature on this topic indicates that ADMH has a significant adverse impact on QoL, likely to a greater degree than melasma, and to a similar or lesser degree than vitiligo. Five of seven studies reported the QoL impairment for patients with ADMH based on the Dermatology Life Quality Index (DLQI); these studies consistently found a mean DLQI score reflective of a moderate effect on patients’ QoL. Clinicians must be aware of the significant psychosocial burden associated with ADMH. This impact is often overlooked but should be considered when taking a holistic approach to management.
7 March 2023 in Medical Journal of Australia